Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125015302 | 12501530 | 2 | F | 20140528 | 20160811 | 20160627 | 20160825 | EXP | US-BAYER-2016-100729 | BAYER | 68.00 | YR | E | F | Y | 87.10000 | KG | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125015302 | 12501530 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | UNK | Y | N | UNKNOWN | 0 | FILM-COATED TABLET | ||||||
| 125015302 | 12501530 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 10 MG, UNK | Y | N | UNKNOWN | 0 | 10 | MG | FILM-COATED TABLET | ||||
| 125015302 | 12501530 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 10 MG, UNK | Y | N | UNKNOWN | 0 | 10 | MG | FILM-COATED TABLET | ||||
| 125015302 | 12501530 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 10 MG, UNK | Y | N | UNKNOWN | 0 | 10 | MG | FILM-COATED TABLET | ||||
| 125015302 | 12501530 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 10 MG, UNK | Y | N | UNKNOWN | 0 | 10 | MG | FILM-COATED TABLET | ||||
| 125015302 | 12501530 | 6 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 10 MG, UNK | Y | N | UNKNOWN | 0 | 10 | MG | FILM-COATED TABLET | ||||
| 125015302 | 12501530 | 7 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Oral | UNK | U | 999999 | TABLET | ||||||||
| 125015302 | 12501530 | 8 | SS | One A Day Omega-3 Fish Oil | FISH OILOMEGA-3 FATTY ACIDS | 1 | Oral | UNK | U | 0 | CAPSULE, SOFT | ||||||||
| 125015302 | 12501530 | 9 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | 0 | 75 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125015302 | 12501530 | 1 | Thrombosis prophylaxis |
| 125015302 | 12501530 | 2 | Atrial fibrillation |
| 125015302 | 12501530 | 3 | Cerebrovascular accident prophylaxis |
| 125015302 | 12501530 | 4 | Thrombosis prophylaxis |
| 125015302 | 12501530 | 5 | Thrombosis prophylaxis |
| 125015302 | 12501530 | 6 | Thrombosis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125015302 | 12501530 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125015302 | 12501530 | Acute kidney injury | |
| 125015302 | 12501530 | Inappropriate schedule of drug administration | |
| 125015302 | 12501530 | Off label use | |
| 125015302 | 12501530 | Upper gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125015302 | 12501530 | 1 | 201404 | 201505 | 0 | |
| 125015302 | 12501530 | 2 | 20150928 | 0 | ||
| 125015302 | 12501530 | 3 | 20140528 | 20150517 | 0 | |
| 125015302 | 12501530 | 4 | 20140702 | 20140924 | 0 | |
| 125015302 | 12501530 | 5 | 20150302 | 20150525 | 0 | |
| 125015302 | 12501530 | 6 | 20141216 | 20150310 | 0 |